CorMedix Non-Current Deferred Revenue (Quarterly) Analysis

CorMedix, Inc. (CRMD)

7.63 +0.12 (+1.60%) USD | NASDAQ | Jan 09, 16:00

7.67 +0.04 (+0.52%) After-Hours: 06:00

View Non-Current Deferred Revenue (Quarterly) for CRMD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	--
Pfizer Inc.	--
Arcutis Biotherapeutics, Inc.	--
ANI Pharmaceuticals, Inc.	--
Alkermes Plc	--